Bleomycin induced epithelial-mesenchymal transition (EMT) in pleural mesothelial cells

Li Jun Chen, Hong Ye, Qian Zhang, Feng Zhi Li, Lin Jie Song, Jie Yang, Qing Mu, Shan Shan Rao, Peng Cheng Cai, Fei Xiang, Jian Chu Zhang, Yunchao Su, Jian Bao Xin, Wan Li Ma

Research output: Contribution to journalArticle

25 Citations (Scopus)

Abstract

Idiopathic pulmonary fibrosis (IPF) is a chronic progressive lung disease characterized by the development of subpleural foci of myofibroblasts that contribute to the exuberant fibrosis. Recent studies revealed that pleural mesothelial cells (PMCs) undergo epithelial-mesenchymal transition (EMT) and play a pivotal role in IPF. In animal model, bleomycin induces pulmonary fibrosis exhibiting subpleural fibrosis similar to what is seen in human IPF. It is not known yet whether bleomycin induces EMT in PMCs. In the present study, PMCs were cultured and treated with bleomycin. The protein levels of collagen-I, mesenchymal phenotypic markers (vimentin and α-smooth muscle actin), and epithelial phenotypic markers (cytokeratin-8 and E-cadherin) were measured by Western blot. PMC migration was evaluated using wound-healing assay of culture PMCs in vitro, and in vivo by monitoring the localization of PMC marker, calretinin, in the lung sections of bleomycin-induced lung fibrosis. The results showed that bleomycin induced increases in collagen-I synthesis in PMC. Bleomycin induced significant increases in mesenchymal phenotypic markers and decreases in epithelial phenotypic markers in PMC, and promoted PMC migration in vitro and in vivo. Moreover, TGF-β1-Smad2/3 signaling pathway involved in the EMT of PMC was demonstrated. Taken together, our results indicate that bleomycin induces characteristic changes of EMT in PMC and the latter contributes to subpleural fibrosis.

Original languageEnglish (US)
Pages (from-to)75-82
Number of pages8
JournalToxicology and Applied Pharmacology
Volume283
Issue number2
DOIs
StatePublished - Mar 1 2015

Fingerprint

Epithelial-Mesenchymal Transition
Bleomycin
Idiopathic Pulmonary Fibrosis
Fibrosis
Collagen
Cell Movement
Keratin-8
Calbindin 2
Pulmonary diseases
Lung
Vimentin
Cadherins
Myofibroblasts
Pulmonary Fibrosis
Muscle
Actins
Assays
Wound Healing
Animals
Lung Diseases

Keywords

  • Bleomycin
  • Collagen
  • Epithelial-mesenchymal transition (EMT)
  • Fibrosis
  • Lung
  • Pleural mesothelial cell

ASJC Scopus subject areas

  • Toxicology
  • Pharmacology

Cite this

Bleomycin induced epithelial-mesenchymal transition (EMT) in pleural mesothelial cells. / Chen, Li Jun; Ye, Hong; Zhang, Qian; Li, Feng Zhi; Song, Lin Jie; Yang, Jie; Mu, Qing; Rao, Shan Shan; Cai, Peng Cheng; Xiang, Fei; Zhang, Jian Chu; Su, Yunchao; Xin, Jian Bao; Ma, Wan Li.

In: Toxicology and Applied Pharmacology, Vol. 283, No. 2, 01.03.2015, p. 75-82.

Research output: Contribution to journalArticle

Chen, LJ, Ye, H, Zhang, Q, Li, FZ, Song, LJ, Yang, J, Mu, Q, Rao, SS, Cai, PC, Xiang, F, Zhang, JC, Su, Y, Xin, JB & Ma, WL 2015, 'Bleomycin induced epithelial-mesenchymal transition (EMT) in pleural mesothelial cells', Toxicology and Applied Pharmacology, vol. 283, no. 2, pp. 75-82. https://doi.org/10.1016/j.taap.2015.01.004
Chen, Li Jun ; Ye, Hong ; Zhang, Qian ; Li, Feng Zhi ; Song, Lin Jie ; Yang, Jie ; Mu, Qing ; Rao, Shan Shan ; Cai, Peng Cheng ; Xiang, Fei ; Zhang, Jian Chu ; Su, Yunchao ; Xin, Jian Bao ; Ma, Wan Li. / Bleomycin induced epithelial-mesenchymal transition (EMT) in pleural mesothelial cells. In: Toxicology and Applied Pharmacology. 2015 ; Vol. 283, No. 2. pp. 75-82.
@article{ca3b6ccd004f4535b64730204dac6483,
title = "Bleomycin induced epithelial-mesenchymal transition (EMT) in pleural mesothelial cells",
abstract = "Idiopathic pulmonary fibrosis (IPF) is a chronic progressive lung disease characterized by the development of subpleural foci of myofibroblasts that contribute to the exuberant fibrosis. Recent studies revealed that pleural mesothelial cells (PMCs) undergo epithelial-mesenchymal transition (EMT) and play a pivotal role in IPF. In animal model, bleomycin induces pulmonary fibrosis exhibiting subpleural fibrosis similar to what is seen in human IPF. It is not known yet whether bleomycin induces EMT in PMCs. In the present study, PMCs were cultured and treated with bleomycin. The protein levels of collagen-I, mesenchymal phenotypic markers (vimentin and α-smooth muscle actin), and epithelial phenotypic markers (cytokeratin-8 and E-cadherin) were measured by Western blot. PMC migration was evaluated using wound-healing assay of culture PMCs in vitro, and in vivo by monitoring the localization of PMC marker, calretinin, in the lung sections of bleomycin-induced lung fibrosis. The results showed that bleomycin induced increases in collagen-I synthesis in PMC. Bleomycin induced significant increases in mesenchymal phenotypic markers and decreases in epithelial phenotypic markers in PMC, and promoted PMC migration in vitro and in vivo. Moreover, TGF-β1-Smad2/3 signaling pathway involved in the EMT of PMC was demonstrated. Taken together, our results indicate that bleomycin induces characteristic changes of EMT in PMC and the latter contributes to subpleural fibrosis.",
keywords = "Bleomycin, Collagen, Epithelial-mesenchymal transition (EMT), Fibrosis, Lung, Pleural mesothelial cell",
author = "Chen, {Li Jun} and Hong Ye and Qian Zhang and Li, {Feng Zhi} and Song, {Lin Jie} and Jie Yang and Qing Mu and Rao, {Shan Shan} and Cai, {Peng Cheng} and Fei Xiang and Zhang, {Jian Chu} and Yunchao Su and Xin, {Jian Bao} and Ma, {Wan Li}",
year = "2015",
month = "3",
day = "1",
doi = "10.1016/j.taap.2015.01.004",
language = "English (US)",
volume = "283",
pages = "75--82",
journal = "Toxicology and Applied Pharmacology",
issn = "0041-008X",
publisher = "Academic Press Inc.",
number = "2",

}

TY - JOUR

T1 - Bleomycin induced epithelial-mesenchymal transition (EMT) in pleural mesothelial cells

AU - Chen, Li Jun

AU - Ye, Hong

AU - Zhang, Qian

AU - Li, Feng Zhi

AU - Song, Lin Jie

AU - Yang, Jie

AU - Mu, Qing

AU - Rao, Shan Shan

AU - Cai, Peng Cheng

AU - Xiang, Fei

AU - Zhang, Jian Chu

AU - Su, Yunchao

AU - Xin, Jian Bao

AU - Ma, Wan Li

PY - 2015/3/1

Y1 - 2015/3/1

N2 - Idiopathic pulmonary fibrosis (IPF) is a chronic progressive lung disease characterized by the development of subpleural foci of myofibroblasts that contribute to the exuberant fibrosis. Recent studies revealed that pleural mesothelial cells (PMCs) undergo epithelial-mesenchymal transition (EMT) and play a pivotal role in IPF. In animal model, bleomycin induces pulmonary fibrosis exhibiting subpleural fibrosis similar to what is seen in human IPF. It is not known yet whether bleomycin induces EMT in PMCs. In the present study, PMCs were cultured and treated with bleomycin. The protein levels of collagen-I, mesenchymal phenotypic markers (vimentin and α-smooth muscle actin), and epithelial phenotypic markers (cytokeratin-8 and E-cadherin) were measured by Western blot. PMC migration was evaluated using wound-healing assay of culture PMCs in vitro, and in vivo by monitoring the localization of PMC marker, calretinin, in the lung sections of bleomycin-induced lung fibrosis. The results showed that bleomycin induced increases in collagen-I synthesis in PMC. Bleomycin induced significant increases in mesenchymal phenotypic markers and decreases in epithelial phenotypic markers in PMC, and promoted PMC migration in vitro and in vivo. Moreover, TGF-β1-Smad2/3 signaling pathway involved in the EMT of PMC was demonstrated. Taken together, our results indicate that bleomycin induces characteristic changes of EMT in PMC and the latter contributes to subpleural fibrosis.

AB - Idiopathic pulmonary fibrosis (IPF) is a chronic progressive lung disease characterized by the development of subpleural foci of myofibroblasts that contribute to the exuberant fibrosis. Recent studies revealed that pleural mesothelial cells (PMCs) undergo epithelial-mesenchymal transition (EMT) and play a pivotal role in IPF. In animal model, bleomycin induces pulmonary fibrosis exhibiting subpleural fibrosis similar to what is seen in human IPF. It is not known yet whether bleomycin induces EMT in PMCs. In the present study, PMCs were cultured and treated with bleomycin. The protein levels of collagen-I, mesenchymal phenotypic markers (vimentin and α-smooth muscle actin), and epithelial phenotypic markers (cytokeratin-8 and E-cadherin) were measured by Western blot. PMC migration was evaluated using wound-healing assay of culture PMCs in vitro, and in vivo by monitoring the localization of PMC marker, calretinin, in the lung sections of bleomycin-induced lung fibrosis. The results showed that bleomycin induced increases in collagen-I synthesis in PMC. Bleomycin induced significant increases in mesenchymal phenotypic markers and decreases in epithelial phenotypic markers in PMC, and promoted PMC migration in vitro and in vivo. Moreover, TGF-β1-Smad2/3 signaling pathway involved in the EMT of PMC was demonstrated. Taken together, our results indicate that bleomycin induces characteristic changes of EMT in PMC and the latter contributes to subpleural fibrosis.

KW - Bleomycin

KW - Collagen

KW - Epithelial-mesenchymal transition (EMT)

KW - Fibrosis

KW - Lung

KW - Pleural mesothelial cell

UR - http://www.scopus.com/inward/record.url?scp=84921850946&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84921850946&partnerID=8YFLogxK

U2 - 10.1016/j.taap.2015.01.004

DO - 10.1016/j.taap.2015.01.004

M3 - Article

C2 - 25595642

AN - SCOPUS:84921850946

VL - 283

SP - 75

EP - 82

JO - Toxicology and Applied Pharmacology

JF - Toxicology and Applied Pharmacology

SN - 0041-008X

IS - 2

ER -